c-Ki-ras mutations in peripheral blood of pancreatic cancer patients: A marker for early tumor metastasis

International Journal of Radiation Oncology Biology Physics

Volumn 34, Issue 1, 1996, Pages 161-166

  Mohiuddin, Mohammed ^a   Ahmed, Mansoor M ^a   Venkatasubbarao, Kolaparthi ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

c Ki ras; Circulating minimal malignant clone (CMMC); Pancreatic adenocarcinoma; Peripheral blood; Point mutation; Polymerase chain reaction (PCR)

Indexed keywords

DNA; TUMOR MARKER;

ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DIAGNOSTIC TEST; HUMAN; METASTASIS; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0030044375     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(95)02004-7     Document Type: Article

References (26)

1. Almoguera, C.; Shibata, D.; Forreste, K.; Martin, J.; Perucho, M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53:549-554; 1988.
2. Beahrs, O. H.; Henson, D. E.; Hutter, R. V. P.; Myers, M. H. Manual for staging of cancer. 3rd ed. Philadelphia: J. B. Lippincott; 1988.
3. Boring, C. C.; Squires, T. S.; Tong, T.; Montogomery, S. Cancer statistics. CA Cancer J. Clin. 44:7-26; 1994.
4. Bos, J. L. ras Oncogenes in human cancer: A review [published erratum appears in Cancer Res. 50: 1990]. Cancer Res. 49:4682-4689; 1989.
5. Caldas, C.; Hahn, S. A.; Hruban, R. H.; Redston, M. S.; Yeo, J. C.; Kern, S. E. Detection of K-ras mutations in stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res. 54:3568-3573; 1994.
6. Cerney, W. L.; Mangold, K. A.; Scarpelli, D. G. K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster. Cancer Res. 52:4507-4513; 1992.
7. Cuschieri, A. Laparoscopy for pancreatic cancer: Does it benefit the patient? Eur. J. Surg. Oncol. 14:41-44; 1988.
8. Grünewald, K.; Lyons, J.; Fröhlich, A.; Feichtinger, H.; Weger, R. A.; Schwab, G.; Janssen, J. W. G.; Bartram, C. R. High frequency of Ki-ras codon 12 mutation in pancreatic adenocarcinoma. Int. J. Cancer 43:1037-1041; 1989.
9. Hruban, R. H.; van Mansfield, A. D. M.; Offerhaus, G. J. A.; van Weering, D. H. J.; Allison, D. C.; Goodman, S. N.; Kensler, T. W.; Bose, K. K.; Camron, J. L.; Bos, J. L. K-ras oncogene activation in adenocarcinoma of human pancreas. A study of 82 carcinomas using combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am. J. Pathol. 143:545-554; 1993.
10. Katz, A. E.; Olsson, C. A.; Raffo, A. J.; Cama, C.; Perlman, H.; Seaman, E.; O'Toole, K. M.; McMahon, D.; Benson, C. M.; Buttyan, R. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology 43:765-775; 1994.
11. Kwok, S.; Higuchi, R. Avoiding false positives with PCR. Nature 339:237-238; 1989.
12. Mansoor, A. M.; Bharadwaj, T. P. R.; Sethuraman, S.; Chandy, M.; Pushpa, V.; Kamada, N.; Murthy, P. B. K. Analysis of karyotype, SCE, and point mutation of RAS oncogene in Indian MDS patients. Cancer Genet. Cytogenet. 65:12-20; 1993.
13. Mariyama, M.; Kishi, K.; Nakamura, K.; Obata, H.; Nishimura, S. Frequency and type of point mutation at the 12th Codon of the c-K-ras gene found in pancreatic cancer from Japanese patients. Jpn. J. Cancer Res. 80:622-626; 1989.
14. Saluz, H. P.; Jost, J. P. A laboratory guide to genomic sequencing. Boston: Birkhaeuser; 1987.
15. Shibata, D.; Capella, G.; Perucho, M. Mutational activation of c-K-ras gene in human pancreatic cancer. Baillieres Clin. Gastroenterol. 4:151-169; 1990.
16. Shibata, D.; Hu, E.; Weiss, L. M.; Brynes, R. K.; Nathwari, B. N. Detection of specific t(14; 18) chromosomal translocation in fixed tissues. Hum. Pathol. 21:199-203; 1990.
17. Tada, M.; Omata, M.; Kawai, S.; Saisho, H.; Ohto, M.; Saiki, R. K.; Sninsky, J. J. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res. 53:2472-2474; 1993.
18. Tarin, D.; Price, J. E.; Kettlewell, M. G. W.; Souter, R. G.; Vass, A. C. R.; Corssley, B. Clinico pathologic observation on metastases in man studied in patients treated with peritoneo-venous strunts. Br. Med. J. 288:749-51; 1984.
19. Tsuchiya, R.; Noda, T.; Harada, N.; Miyamoto, T.; Tomioka, T.; Yamamoto, K.; Yamaguchi, T.; Izawa, K.; Tsunoda, T.; Yoshino, R.; Eto, T. Collective review of small carcinomas of the pancreas. Ann. Surg. 203:77-81; 1986.
20. Urban, T.; Ricci, S.; Grange, J.-D.; Lacave, R.; Boudghene, F.; Breittmayer, F.; Languille, O.; Bernaudin, J.-F. Detection of c-K-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas. J. Natl. Cancer Inst. 85:2008-2012; 1993.
21. Warshaw, A. L.; Castillo, C. F. Pancreatic carcinoma. N. Engl. J. Med. 326:455-465; 1992.
22. Warshaw, A. L.; Gu, Z.; Wittenberg, J.; Walthun, A. Preoperative staging and assessment of resectability of pancreatic cancer. Arch. Surg. 125:230-233; 1990.
23. Warshaw, A. L.; Tepper, J. E.; Shipley, W. O. Laparoscopy in the staging and planning of therapy for pancreatic cancer. Am. J. Surg. 151:76-80; 1986.
24. Weiss, S. M.; Skibber, J. M.; Mohiuddin, M.; Rosato, F. E. Rapid intraabdominal spread of pancreatic cancer. Arch. Surg. 120:415-416; 1985.
25. Wijnholds, J.; Philipsen, J. N. J.; Ab, G. Tissue-specific and steroid-dependent interaction of transcription factors with the oestrogen-inducible apo VLDL II promoter in vivo. EMBO J. 7:2757; 1988.
26. Yamada, H.; Sakamoto, H.; Taira, M.; Nishimura, S.; Shimosato, Y.; Terada, M.; Sugimura, T. Amplifications of c-Ki-ras with a point mutation and c-myc in primary pancreatic cancer and its metastatic tumors in lymphnodes. Jpn. J. Cancer Res. 77:370-375; 1986.